This article was originally published on PharmaTimes http://www.pharmatimes.com/news/pairing_targeted_drugs_could_overcome_breast,_lung_cancer_treatment_resistance_1294450

The new data could broaden the clinical use of palbociclib – and other drugs that work in the same way – beyond breast cancer to include many other tumour types as well.

Related Posts